Michael Jay Ross - Net Worth and Insider Trading
Michael Jay Ross Net Worth
The estimated net worth of Michael Jay Ross is at least $3 Million dollars as of 2024-11-10. Michael Jay Ross is the Director, 10% Owner of X4 Pharmaceuticals Inc and owns about 5,561,466 shares of X4 Pharmaceuticals Inc (XFOR) stock worth over $3 Million. Details can be seen in Michael Jay Ross's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Jay Ross has not made any transactions after 2017-11-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Jay Ross
Michael Jay Ross Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Jay Ross owns 6 companies in total, including Deciphera Pharmaceuticals Inc (DCPH) , Sutro Biopharma Inc (STRO) , and Astria Therapeutics Inc (ATXS) among others .
Click here to see the complete history of Michael Jay Ross’s form 4 insider trades.
Insider Ownership Summary of Michael Jay Ross
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
DCPH | Deciphera Pharmaceuticals Inc | 2017-09-27 | director |
STRO | Sutro Biopharma Inc | 2018-09-26 | director & 10 percent owner |
ATXS | Astria Therapeutics Inc | 2015-06-24 | director |
2017-11-20 | director & 10 percent owner | ||
2017-05-18 | director | ||
2021-10-21 | director |
Michael Jay Ross Latest Holdings Summary
Michael Jay Ross currently owns a total of 1 stock. Michael Jay Ross owns 5,561,466 shares of X4 Pharmaceuticals Inc (XFOR) as of November 20, 2017, with a value of $3 Million.
Latest Holdings of Michael Jay Ross
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
XFOR | X4 Pharmaceuticals Inc | 2017-11-20 | 5,561,466 | 0.62 | 3,434,205 |
Holding Weightings of Michael Jay Ross
Michael Jay Ross Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Jay Ross has made a total of 0 transactions in X4 Pharmaceuticals Inc (XFOR) over the past 5 years. The most-recent trade in X4 Pharmaceuticals Inc is the acquisition of 500,000 shares on November 20, 2017, which cost Michael Jay Ross around $5 Million.
Insider Trading History of Michael Jay Ross
- 1
Michael Jay Ross Trading Performance
GuruFocus tracks the stock performance after each of Michael Jay Ross's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Jay Ross is 0.28%. GuruFocus also compares Michael Jay Ross's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Jay Ross within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Jay Ross's insider trading performs compared to the benchmark.
Performance of Michael Jay Ross
Michael Jay Ross Ownership Network
Ownership Network List of Michael Jay Ross
Ownership Network Relation of Michael Jay Ross
Michael Jay Ross Owned Company Details
What does Deciphera Pharmaceuticals Inc do?
Who are the key executives at Deciphera Pharmaceuticals Inc?
Michael Jay Ross is the director of Deciphera Pharmaceuticals Inc. Other key executives at Deciphera Pharmaceuticals Inc include SVP & Regulatory & Quality Jama Pitman , Chief Commercial Officer Daniel C. Martin , and Chief Financial Officer Thomas Patrick Kelly .
Deciphera Pharmaceuticals Inc (DCPH) Insider Trades Summary
Over the past 18 months, Michael Jay Ross made no insider transaction in Deciphera Pharmaceuticals Inc (DCPH). Other recent insider transactions involving Deciphera Pharmaceuticals Inc (DCPH) include a net sale of 23,797 shares made by Daniel C. Martin , a net sale of 12,184 shares made by Matthew L Sherman , and a net sale of 9,198 shares made by Thomas Patrick Kelly .
In summary, during the past 3 months, insiders sold 0 shares of Deciphera Pharmaceuticals Inc (DCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 105,002 shares of Deciphera Pharmaceuticals Inc (DCPH) were sold and 10,000 shares were bought by its insiders, resulting in a net sale of 95,002 shares.
Deciphera Pharmaceuticals Inc (DCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Deciphera Pharmaceuticals Inc Insider Transactions
Michael Jay Ross Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Jay Ross. You might contact Michael Jay Ross via mailing address: C/o Sv Health Investors, Llc, One Boston Plc, 201 Washington St. #3900, Boston Ma 02108.